SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Money market funds	$ 4,326
Cash equivalents		$ 0
Intangible assets useful life	5 years
Amortization expenses	$ 160	160
Intangible assets unamortized balance	62	222
Impairment of intangible assets	0	0
Deferred offering costs	$ 1,091	$ 1,377
Deferred tax assets valuation allowance, percentage	100.00%	100.00%
Patent expenses	$ 3,437	$ 1,929
Research and developments costs	2,135	414
Patents [Member]
Restructuring Cost and Reserve [Line Items]
Patent expenses	79	134
Equity Line of Credit [Member]
Restructuring Cost and Reserve [Line Items]
Deferred offering costs	614	$ 1,377
Deferred offering additional cost	$ 328
Enviro Threapeutics Inc [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition cost			$ 800